Gene selection for the Australian Reproductive Genetic Carrier Screening Project ("Mackenzie's Mission")

Simple item page
dc.contributor.authorKirk, E.P.
dc.contributor.authorOng, R.
dc.contributor.authorBoggs, K.
dc.contributor.authorHardy, T.
dc.contributor.authorRighetti, S.
dc.contributor.authorBen, K.
dc.contributor.authorRoscioli, T.
dc.contributor.authorAmor, D.J.
dc.contributor.authorBakshi, M.
dc.contributor.authorChung, C.W.T.
dc.contributor.authorColley, A.
dc.contributor.authorJamieson, R.
dc.contributor.authorLiebelt, J.
dc.contributor.authorMa, A.
dc.contributor.authorPachter, N.
dc.contributor.authorRajagopalan, S.
dc.contributor.authorRavine, A.
dc.contributor.authorWilson, M.
dc.contributor.authorCaruana, J.
dc.contributor.authorCasella, R.
dc.contributor.authoret al.
dc.date.issued2021
dc.descriptionPublished online: 16 July 2020
dc.description.abstractReproductive genetic carrier screening aims to offer couples information about their chance of having children with certain autosomal recessive and X-linked genetic conditions. We developed a gene list for use in "Mackenzie's Mission", a research project in which 10,000 couples will undergo screening. Criteria for selecting genes were: the condition should be life-limiting or disabling, with childhood onset, such that couples would be likely to take steps to avoid having an affected child; and/or be one for which early diagnosis and intervention would substantially change outcome. Strong evidence for gene-phenotype relationship was required. Candidate genes were identified from OMIM and via review of 23 commercial and published gene lists. Genes were reviewed by 16 clinical geneticists using a standard operating procedure, in a process overseen by a multidisciplinary committee which included clinical geneticists, genetic counselors, an ethicist, a parent of a child with a genetic condition and scientists from diagnostic and research backgrounds. 1300 genes met criteria. Genes associated with non-syndromic deafness and non-syndromic differences of sex development were not included. Our experience has highlighted that gene selection for a carrier screening panel needs to be a dynamic process with ongoing review and refinement.
dc.description.statementofresponsibilityEdwin P. Kirk, Royston Ong, Kirsten Boggs, Tristan Hardy, Sarah Righetti, Ben Kamien ... et al.
dc.identifier.citationEuropean Journal of Human Genetics, 2021; 29(1):79-87
dc.identifier.doi10.1038/s41431-020-0685-x
dc.identifier.issn1018-4813
dc.identifier.issn1476-5438
dc.identifier.orcidHardy, T. [0000-0002-5878-0340]
dc.identifier.urihttp://hdl.handle.net/2440/126997
dc.language.isoen
dc.publisherSpringer Nature
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1117510
dc.rights© The Author(s), under exclusive licence to European Society of Human Genetics 2020
dc.source.urihttps://doi.org/10.1038/s41431-020-0685-x
dc.subjectHumans
dc.subjectGenetic Predisposition to Disease
dc.subjectQuantitative Trait Loci
dc.subjectAustralia
dc.subjectConsensus Development Conferences as Topic
dc.subjectGenetic Carrier Screening
dc.titleGene selection for the Australian Reproductive Genetic Carrier Screening Project ("Mackenzie's Mission")
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Pathology publications